Hemophilia News Today compiled a summary of the 10 most read hemophilia stories of 2024, with links to the individual items.

Sangamo Therapeutics said on Monday that partner Pfizer has terminated their hemophilia A gene therapy co-development ...

The biotech company intends to explore ways to move ahead with developing the treatment, including seeking a new collaborator ...

Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.

Sangamo Therapeutics (SGMO) stock plunged as Pfizer (PFE) ends collaboration on hemophilia A gene therapy. Find out the ...

Sangamo Therapeutics' (SGMO) shares were sinking intraday Tuesday after the company said its partner Pfizer (PFE) decided not to proceed with further development of a new gene therapy to treat ...

The bleeding disorder community is served through a ... What are the National Hemophilia Foundation's (NHF) priorities for 2019? Two of NHF’s key priorities for 2019 are access to care and ...

CSL Plasma donation centers that are mature and fully operational annually contribute about $4 million or more in economic activity. #NewsismyBusiness ...

I knew I was bleeding. I was not believed. Persistence over time eventually solved the mystery ... Clues are sometimes found ...

Hemophilia is an inherited, rare blood disorder in which the patient lacks a protein needed for normal blood clotting ... The prince suffered prolonged bouts of bleeding whenever he cut himself ...